文献速递临床试验与 GCP

艾司氯胺酮联合右美托咪定对机械通气ICU患者镇静中谵妄的影响:一项随机对照试验的嵌套子研究方案

Effect of esketamine combined with dexmedetomidine on delirium in sedation for mechanically ventilated ICU patients: protocol for a nested substudy within a randomized controlled trial.
PubMed 文献 · Trials · 2024-07-02

本研究为单中心、随机、阳性对照、优效性试验方案,计划纳入134例机械通气患者,比较单用右美托咪定与艾司氯胺酮联合右美托咪定对谵妄发生率的影响,主要结局为谵妄发生,次要结局包括无谵妄天数、谵妄亚型、严重程度、持续时间、首次发生时间、血管升压药及抗精神病药总剂量、机械通气时长、ICU及住院时长、意外拔管、再插管、再入院及14天和28天ICU死亡率。

要点

  • 拟纳入134例机械通气患者,随机接受单用右美托咪定或艾司氯胺酮联合右美托咪定。
  • 主要结局为谵妄发生,次要结局包括无谵妄天数、谵妄亚型及严重程度等。
  • 研究旨在评估联合方案能否减少右美托咪定的副作用及谵妄风险。

核心结论

  • 该子研究将评估艾司氯胺酮联合右美托咪定降低ICU机械通气患者谵妄风险的效果,从而为改善短期预后提供证据。

研究设计与样本

  • 单中心、随机、阳性对照、优效性试验,在南京医科大学第一附属医院开展,计划招募134例机械通气患者。
  • 患者随机接受单用右美托咪定或艾司氯胺酮联合右美托咪定,直至拔管或最长14天。

主要发现

  • 主要结局为谵妄发生;次要结局包括无谵妄天数、谵妄亚型、严重程度、持续时间、首次发生时间、血管升压药及抗精神病药总剂量、机械通气时长、ICU及住院时长、意外拔管、再插管、再入院及14天和28天ICU死亡率。

关键数值与推荐

  • 计划样本量为134例机械通气患者。
  • 干预持续至拔管或最长14天。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of sedatives and analgesics is associated with the occurrence of delirium in critically ill patients receiving mechanical ventilation. Dexmedetomidine reduces the occurrence of delirium but may cause hypotension, bradycardia, and insufficient sedation. This substudy aims to determine whether the combination of esketamine with dexmedetomidine can reduce the side effects and risk of delirium than dexmedetomidine alone in mechanically ventilated patients. METHODS: This single-center, randomized, active-controlled, superiority trial will be conducted at The First Affiliated Hospital of Nanjing Medical University. A total of 134 mechanically ventilated patients will be recruited and randomized to receive either dexmedetomidine alone or esketamine combined with dexmedetomidine, until extubation or for a maximum of 14 days. The primary outcome is the occurrence of delirium, while the second outcomes include the number of delirium-free days; subtype, severity, and duration of delirium; time to first onset of delirium; total dose of vasopressors and antipsychotics; duration of mechanical ventilation; ICU and hospital length of stay (LOS); accidental extubation, re-intubation, re-admission; and mortality in the ICU at 14 and 28 days. DISCUSSION: There is an urgent need for a new combination regimen of dexmedetomidine due to its evident side effects. The combination of esketamine and dexmedetomidine has been applied throughout the perioperative period. However, there is still a lack of evidence on the effects of this regimen on delirium in mechanically ventilated ICU patients. This substudy will evaluate the effects of the combination of esketamine and dexmedetomidine in reducing the risk of delirium for mechanically ventilated patients in ICU, thus providing evidence of this combination to improve the short-term prognosis. The study protocol has obtained approval from the Medical Ethics Committee (ID: 2022-SR-450). TRIAL REGISTRATION: ClinicalTrials.gov: NCT05466708, registered on 20 July 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang W, You J, Hu J, et al. Effect of esketamine combined with dexmedetomidine on delirium in sedation for mechanically ventilated ICU patients: protocol for a nested substudy within a randomized controlled trial. Trials. 2024. PMID: 38956664. doi:10.1186/s13063-024-08287-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。